Multi-state cannabis operator Curaleaf said it has decided to wind down its hemp-derived THC business.
The decision comes after last year congress passed legislation that affectively bans hemp THC. The new language is designed to prevent the unregulated sale of intoxicating hemp-based or hemp-derived products, including Delta-8, from being sold online, in gas stations, and corner stores, while preserving non-intoxicating CBD and industrial hemp products. It’s not scheduled to take effect until November 2026.
But Curaleaf has decided to jump ship now. In the past few years, the company has taken tentative steps into the hemp-derived THC market. That includes launching multiple hemp THC beverages and opening its first dedicated hemp THC retail store in Florida.
Curaleaf has also decided to exit the Missouri cannabis market, citing a "sub-scale presence in the state [that] did not justify continued investment." The company said its hemp-derived THC and Missouri business units represented about $2 million in revenue during the third and fourth quarters of 2025.
The changes are all part of what Curaleaf CEO Boris Jordan calls a "Return to Our Roots" strategy, and it's a shift that the company said is boost its fourth-quarter results. According to preliminary figures released by the company, Curaleaf's Q4 revenue grew about 4% sequentially.
